Gilead Aims For Oncology To Provide One-Third Of Revenues By 2030

Digital illustration of Cancer cell in colour background
Gilead is planning to make a big push in oncology in 2022 • Source: Shutterstock

More from Immuno-oncology

More from Anticancer